Clough Capital Partners L P Purchases Shares of 173,010 Select Medical Holdings Corporation $SEM

Clough Capital Partners L P purchased a new stake in shares of Select Medical Holdings Corporation (NYSE:SEM) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 173,010 shares of the health services provider’s stock, valued at approximately $2,569,000. Clough Capital Partners L P owned approximately 0.14% of Select Medical as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Quarry LP bought a new position in shares of Select Medical during the fourth quarter valued at about $26,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Select Medical during the fourth quarter valued at about $28,000. Quantbot Technologies LP bought a new position in shares of Select Medical during the third quarter valued at about $27,000. Hantz Financial Services Inc. grew its stake in shares of Select Medical by 214.7% during the fourth quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock valued at $38,000 after buying an additional 1,739 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its stake in shares of Select Medical by 37.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after buying an additional 788 shares during the last quarter. 89.48% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on SEM shares. Wall Street Zen cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Weiss Ratings raised Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, June 4th. Mizuho reaffirmed a “neutral” rating and set a $16.50 price objective (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $16.50 target price (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. One equities research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, Select Medical presently has an average rating of “Hold” and an average target price of $15.50.

Select Medical Stock Performance

Shares of SEM opened at $16.54 on Thursday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.15 and a quick ratio of 1.15. Select Medical Holdings Corporation has a one year low of $11.65 and a one year high of $16.99. The company has a 50-day simple moving average of $16.48 and a two-hundred day simple moving average of $15.86. The firm has a market capitalization of $2.05 billion, a PE ratio of 15.60, a price-to-earnings-growth ratio of 0.96 and a beta of 1.01.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter last year, the business earned $0.44 earnings per share. The business’s quarterly revenue was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, analysts anticipate that Select Medical Holdings Corporation will post 1.26 EPS for the current fiscal year.

Select Medical declared that its board has initiated a stock buyback plan on Thursday, February 19th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the health services provider to purchase up to 49.5% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board believes its shares are undervalued.

Select Medical Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were issued a $0.0625 dividend. The ex-dividend date was Thursday, May 14th. This represents a $0.25 annualized dividend and a yield of 1.5%. Select Medical’s dividend payout ratio (DPR) is 23.58%.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.